This podcast discusses when patients who are at high risk of cardiovascular disease should be comanaged by primary care providers and lipidologists.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

166460 11/21


Yehuda Handelsman, MD, FACP, FNLA, MACE

Medical Director & Principal Investigator
The Metabolic Institute of America